Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Universe Pharmaceuticals ( (UPC) ) has issued an announcement.
On August 26, 2025, Universe Pharmaceuticals INC had to adjourn its 2025 annual general meeting due to a lack of quorum. The meeting has been rescheduled to September 2, 2025, at the same location in Ji’an City, China. This adjournment may impact the company’s operational timelines and decision-making processes, potentially affecting stakeholders awaiting outcomes from the meeting.
The most recent analyst rating on (UPC) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Universe Pharmaceuticals stock, see the UPC Stock Forecast page.
Spark’s Take on UPC Stock
According to Spark, TipRanks’ AI Analyst, UPC is a Neutral.
Universe Pharmaceuticals faces significant financial and operational challenges, reflected in its poor financial performance and valuation scores. The technical analysis indicates a bearish trend, further impacting the overall score.
To see Spark’s full report on UPC stock, click here.
More about Universe Pharmaceuticals
Universe Pharmaceuticals INC operates in the pharmaceutical industry, focusing on the development and distribution of traditional Chinese medicine products. The company is based in Ji’an, Jiangxi, China, and serves a market that values traditional medicinal practices.
Average Trading Volume: 59,843
Technical Sentiment Signal: Sell
Current Market Cap: $2.01M
See more data about UPC stock on TipRanks’ Stock Analysis page.